< Back to situations

Monitor this situation.

[SITUATION] · [QUIET] · [HEALTH]

2 clusters · 5 sources · 3 days · First seen · Last updated

Medical AI and clinical research advancements in South Korea

Overview

Medical advancements in South Korea have increasingly focused on the integration of artificial intelligence within clinical research and diagnostics.

At the 40th Annual Meeting of the Korean Neurosurgical Society, researchers demonstrated a hybrid AI model that uses human input to improve the accuracy of MRI analysis for degenerative cervical myelopathy. Additionally, clinical data was presented regarding musculoskeletal treatments and global Phase 3 trial results for a denosumab biosimilar used in osteoporosis treatment.

Further developments in the field include the selection of Deepnoid for the ‘Korean ARPA-H Project’. This initiative aims to develop a multimodal foundation model to monitor elderly mental health by integrating brain-computer interfaces, brain imaging, and bio-signals. Concurrently, medical experts at the ‘AI Medical Imaging Biomarker 2026’ symposium discussed using AI to quantify disease progression and treatment responses through CT, MRI, and PET scans to serve as reliable biomarkers in drug development.

Entities

Seoul Asan Medical Center · Ministry of Health and Welfare · Samsung Seoul Hospital · Deepnoid · Korea Health Industry Development Institute

Claims

What the coverage asserts, and how many sources carry each claim.

Timeline

  1. [TECHNOLOGY] 4 sources
    Deepnoid joins 18 billion KRW Korean ARPA-H project for elderly mental health AI

    Deepnoid joins a 18 billion KRW Korean ARPA-H project to develop AI for elderly mental health, while Seoul Asan Medical Center hosts a symposium on AI medical imaging biomarkers for drug development.

  2. [HEALTH] 3 sources
    Korean Neurosurgical Society highlights AI spinal research and new clinical data

    At the Korean Neurosurgical Society meeting, researchers showcased AI-enhanced MRI analysis for spinal conditions, while Hanmi Pharmaceutical presented clinical data for low back pain and osteoporosis drugs.

Sources

biotimes.co.kr · bokuennews.com · bosa.co.kr · healthmedia.co.kr · hin.company